Private Equity, VC & Investor
360 Capital vs Breega
Structured technology and market comparison · 2026
Direct Feature Comparison
360 Capital · vs · BreegaFrench venture capital firm managing and deploying investment funds.
European and African early-stage venture capital fund manager.
Analyze all overlapping signals and tech stacks for 360 Capital and Breega
Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.
Comparison Analysis
What is the main difference between 360 Capital and Breega?
When comparing 360 Capital and Breega, both platforms operate within the Private Equity, VC & Investor ecosystem. 360 Capital is positioned as French venture capital firm managing and deploying investment funds, whereas Breega focuses on European and African early-stage venture capital fund manager. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.
What are the top alternatives to 360 Capital and Breega?
When evaluating 360 Capital and Breega, enterprise buyers also consider other platforms in Private Equity, VC & Investor. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.
How do the corporate scale, structure, and headquarters of 360 Capital and Breega compare?
360 Capital is headquartered in FR (founded in 1997) with 10–49 employees. Breega is based in FR (founded in 2013) with 10–49 employees. Complete ownership, subsidiary trees, and corporate affiliations are documented across Polaris7.
Market Signals
Recent Market Signals & Activity: 360 Capital vs Breega
Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.
360 Capital
Recent Signals
- ·Tech.eu (European Tech & Deals)Infrastructure
Bynario Raises €2.1M for AI Vulnerability Platform
Milan-based cybersecurity startup Bynario has raised €2.1 million in a pre-seed funding round led by 360 Capital Partners, with participation from Prana Ventures. Founded in 2025, Bynario develops an autonomous application security platform that identifies, validates, prioritizes, and remediates software vulnerabilities across code, cloud infrastructure, and the software supply chain. The company gained attention after its researchers used AI models to uncover serious vulnerabilities in Apple's macOS Screen Sharing technology, which Apple subsequently patched. The funding will support platform development, engineering team expansion, and scaling for enterprise customers. Bynario aims to address the growing complexity of software and AI-assisted attacks by confirming which vulnerabilities are actually exploitable in a customer's environment.
- Bynario raised €2.1 million in a pre-seed funding round led by 360 Capital Partners with participation from Prana Ventures.
- Founded in 2025, Bynario develops an AI-powered platform for identifying, validating, prioritizing, and remediating software vulnerabilities.
- Bynario's researchers used AI models to discover serious vulnerabilities in Apple's macOS Screen Sharing technology, later patched by Apple.
Breega
Recent Signals
- ·EU-Startups (European Venture)Funding
Cori Clinical Raises €3.8M to Accelerate Clinical Trials
London-based Cori Clinical, a startup providing an AI-powered intelligence layer for clinical trials, has raised €3.8 million in a Seed round led by Breega, with participation from Enzo, Heartfelt, Together Ventures, and Bynd. The company plans to use the funds to expand delivery capacity, grow its team, and deepen regulatory and clinical intelligence in its platform. Dr. Emma Ogburn joins as Chief Clinical Officer from Lindus Health. Founded in 2025 by Jorn Jansen Schoonhoven (CEO) and Patricio Fernández (CTO), Cori Clinical creates a 'living blueprint' for trials, integrating internal knowledge with external data from registries and regulatory bodies like FDA, MHRA, and EMA. The startup claims its approach could reduce average trial set-up costs by at least 33%. It already works with two of the top five global CROs and has customers like Erasmus MC.
- Cori Clinical raised €3.8 million in a Seed round led by Breega.
- Participants include Enzo, Heartfelt, Together Ventures, and Bynd.
- Dr. Emma Ogburn joins as Chief Clinical Officer from Lindus Health.
Compare their exact ecosystem overlaps.
Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners 360 Capital and Breega share across the market ecosystem.
Unlock full capability matrix, client overlaps & technology stacks